Skip to content
10-Q/A

Quarterly Report

TIBET PHARMACEUTICALS, INC.

0001144204-11-050132

← back to feed
Filed
Aug 29, 2011 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2011 · Jun 30, 2011 14.85M sh
Operating Cash Flow Q2 2011 · Jun 30, 2011 $7.05M
Operating Cash Flow Q2 2011 · Jun 30, 2010 $4.53M
Cash And Equivalents Q2 2011 · Jun 30, 2011 $29.52M
Cash And Equivalents Q2 2011 · Dec 31, 2010 $7.58M
Cash And Equivalents Q2 2011 · Jun 30, 2010 $7.7M
Cash And Equivalents Q2 2011 · Dec 31, 2009 $4.08M
Stockholders Equity Q2 2011 · Jun 30, 2011 $44.98M
Stockholders Equity Q2 2011 · Dec 31, 2010 $23.48M
Stockholders Equity Q2 2011 · Dec 31, 2009 $10.54M
Current Liabilities Q2 2011 · Jun 30, 2011 $4.94M
Current Liabilities Q2 2011 · Dec 31, 2010 $4.71M
Current Assets Q2 2011 · Jun 30, 2011 $43.17M
Current Assets Q2 2011 · Dec 31, 2010 $21.13M
Total Assets Q2 2011 · Jun 30, 2011 $49.92M
Total Assets Q2 2011 · Dec 31, 2010 $28.2M
Sga Expense Q2 2011 · Jun 30, 2011 $363.44K
Sga Expense Q2 2011 · Jun 30, 2011 $1.29M
Sga Expense Q2 2011 · Jun 30, 2010 $668.01K
Sga Expense Q2 2011 · Jun 30, 2010 $1.32M
Net Income Q2 2011 · Jun 30, 2011 $3.53M
Net Income Q2 2011 · Jun 30, 2011 $6.1M
Net Income Q2 2011 · Dec 31, 2010 $13.14M
Net Income Q2 2011 · Jun 30, 2010 $3.38M
Net Income Q2 2011 · Jun 30, 2010 $6.23M
Operating Income Q2 2011 · Jun 30, 2011 $3.5M
Operating Income Q2 2011 · Jun 30, 2011 $6.06M
Operating Income Q2 2011 · Jun 30, 2010 $3.42M
Operating Income Q2 2011 · Jun 30, 2010 $6.31M
Gross Profit Q2 2011 · Jun 30, 2011 $3.87M
Gross Profit Q2 2011 · Jun 30, 2011 $7.34M
Gross Profit Q2 2011 · Jun 30, 2010 $4.09M
Gross Profit Q2 2011 · Jun 30, 2010 $7.64M
Cost Of Revenue Q2 2011 · Jun 30, 2011 $4.88M
Cost Of Revenue Q2 2011 · Jun 30, 2011 $9.64M
Cost Of Revenue Q2 2011 · Jun 30, 2010 $3.74M
Cost Of Revenue Q2 2011 · Jun 30, 2010 $7.22M
Revenue Q2 2011 · Jun 30, 2011 $8.75M
Revenue Q2 2011 · Jun 30, 2011 $16.98M
Revenue Q2 2011 · Jun 30, 2010 $7.83M
Revenue Q2 2011 · Jun 30, 2010 $14.85M
Dividends Paid Q2 2011 · Jun 30, 2010 $2.5M
Capex Q2 2011 · Jun 30, 2010 $139.72K